Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer
The Long Run with Luke Timmerman
00:00
Early Funding and Development Challenges in Biotech Innovation
This chapter delves into the inception of a biotech company funded by Biocon, showcasing the potential of a promising molecule. It highlights the hurdles of establishing credibility in the U.S. investment landscape and the complexities of developing bispecific antibodies for cancer treatment.
Transcript
Play full episode
